Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • suefo
    Member
    • Jul 2011
    • 36

    #1

    FLX+ and amplicons

    Good afternoon all. I understand there are people out there now using the FLX+ with amplicons (which is now fully supported by 454 / Roche). We are contemplating an upgrade from FLX to FLX+ but would appreciate some feedback.

    1. How big are your read lengths?
    2. Do you calculate an error rate and have you tracked between FLX and FLX+
    3. I'm looking over the protocols now, but are there any significant difference in the sequencing methods between FLX and FLX+?
    4. We are looking at 16S. What regions are people using on the FLX+ if also sequencing 16S?
    5. General thoughts or opinions about FLX+ / amplicons?

    Thank you. You can either reply to this thread or email me directly: Sue Foltin@ [email protected]
  • JackieBadger
    Senior Member
    • Mar 2009
    • 385

    #2
    My thoughts on amplicon studies are to avoid 454 and go straight to MiSeq.
    Illumina data is cheaper and less error prone.

    Comment

    • suefo
      Member
      • Jul 2011
      • 36

      #3
      We have a MiSeq... but we need to read across larger regions.

      Comment

      • Dynamac
        Member
        • Aug 2011
        • 46

        #4
        Sue,

        We recently upgraded to FLX+ but haven't carried out any runs other than test runs with control beads. I can tell you that the upgrade went smoothly, was performed on site in about 3 days, including the test run. There is a change in the hardware, but the system is backward compatible in case you still have old sequencing kits that you want to utilize. The protocols change a little, but not significantly. Also, there is an additional maintenance step required every 3 months (replacement of some tubing). And of course, the runs and processing take longer.

        We likely will do 16S eventually, but the first thing we're going try is a shotgun library, prepared by restriction enzyme digestion and genome reduction. We will be doing 700-800 bp COI amplicons soon as well. I can keep you informed if you'd like.

        Barry

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        15 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        13 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        24 views
        0 reactions
        Last Post SEQadmin2  
        Working...